Published in Wien Klin Wochenschr on December 05, 1986
Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclines. Cancer Chemother Pharmacol (1990) 0.75
[Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats]. Z Krebsforsch (1967) 5.30
Modifying risk of developing lung cancer by changing habits of cigarette smoking. Br Med J (Clin Res Ed) (1984) 1.50
Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol (1999) 1.34
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol (2001) 1.33
Investigation of the tumorigenic response to benzo(a)pyrene in aqueous caffeine solution applied orally to Sprague-Dawley rats. J Cancer Res Clin Oncol (1981) 1.31
Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet (1999) 1.24
Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol (1995) 1.17
Occurrence of second tumors in man after anticancer drug treatment. Cancer Treat Rev (1982) 1.13
[Autochtonous animal tumors as test models for cancer chemotherapy]. Mitt Dtsch Pharm Ges Pharm Ges DDR (1970) 1.10
Roundtable discussion: symposium: medical perspectives on passive smoking. Prev Med (1984) 1.02
Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol (1999) 1.01
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study. Ann Oncol (2011) 1.00
Spontaneous vaginal delivery in the birth-chair versus in the conventional dorsal position: a matched controlled comparison. Wien Klin Wochenschr (2001) 0.98
Induction of pancreatic neoplasms by 2,2'-dioxopropyl-N-propylnitrosamine. Cancer Lett (1975) 0.95
Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol (1998) 0.94
Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin. J Cancer Res Clin Oncol (1984) 0.94
[Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents]. Arzneimittelforschung (1970) 0.92
Occurrence of second primary malignancies in man--a second look. Cancer Treat Rev (1985) 0.92
Vesicocutaneous fistula mimicking an abdominal wall abscess 2 years after radical abdominal hysterectomy. Gynecol Oncol (2003) 0.91
Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study. Int J Gynecol Cancer (2006) 0.91
Carcinogenic action of low-dose cyclophosphamide given orally to Sprague-Dawley rats in a lifetime experiment. Int J Cancer (1979) 0.91
Efficacy of new ruthenium complexes against chemically induced autochthonous colorectal carcinoma in rats. Anticancer Res (1989) 0.90
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer. Br J Cancer (2011) 0.90
Investigations on carcinogenic effects of Penicillium caseicolum and P. roqueforti in rats. Experientia (1977) 0.90
[Wound rupture after Misgav-Ladach cesarean section: a case report]. Gynakol Geburtshilfliche Rundsch (2004) 0.90
Chemotherapy studies in autochthonous rat tumors intestinal cancer. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1978) 0.89
Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res (2001) 0.89
Carcinogenicity of N-nitrosodiethanolamine in rats at five different dose levels. Cancer Res (1982) 0.88
Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer (2001) 0.87
Inguinal lymph node metastasis as the only manifestation of lymphatic spread in ovarian cancer: A case report. Gynecol Oncol (1999) 0.86
Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer. Oncol Rep (2000) 0.86
Carcinogenicity of N-nitroso compounds. Species and route differences in regard to organotropism. Oncology (1980) 0.86
Carcinogenesis in different animal specids by diethylnitrosamine. Experientia (1967) 0.85
[Reduced toxicity of dimethylnitrosamine in rats and mice after treatment with disulfiram]. Arzneimittelforschung (1971) 0.85
[Ascorbic acid hinderance of the prenatal carcinogenic effect of ethylurea and nitrite]. Naturwissenschaften (1973) 0.85
[Experimental investigation of "syncarcinogenesis". 4. Studies of the induction of cancer in rats with the simultaneous oral administration of diethylnitrosamine and 4-dimethylaminostilbene]. Z Krebsforsch (1965) 0.85
Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient: a case report. Anticancer Res (2006) 0.85
[Lack of carcinogenic effects of cyclamate, cyclohexylamine, and saccharine in rats]. Arzneimittelforschung (1973) 0.83
Primary serous papillary carcinoma of the peritoneum: a report of 18 patients. Eur J Gynaecol Oncol (1997) 0.83
Comparison between the effects of dietary fat level and of calorie intake on methylnitrosourea-induced mammary carcinogenesis in female SD rats. Int J Cancer (1987) 0.83
[Chemotherapeutic experiments with Endoxan on autochthonous benzpyrene sarcomas in rats and mice]. Z Krebsforsch (1966) 0.83
Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in rats. Int J Cancer (1983) 0.83
Cord blood oxygen saturation in vigorous infants at birth: what is normal? BJOG (2000) 0.82
[Diabetes mellitus and breast cancer. A retrospective follow-up study]. Onkologie (1990) 0.82
The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. Gynecol Oncol (1999) 0.82
Influence of disulfiram on the organotropy of the carcinogenic effect of dimethylnitrosamine and diethylnitrosamine in rats. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.82
Experimental carcinogenesis of antitumour drugs. Cancer Treat Rev (1978) 0.81
[Examination of polyvinylpyridine-N-oxide (PVNO) on the carcinogenic effect in rats and mice]. Arzneimittelforschung (1969) 0.81
In vitro chemosensitivity testing in the treatment of ovarian carcinoma. Arch Gynecol Obstet (1989) 0.81
Locoregional administration of 5-fluoro-2'-deoxyuridine (FdUrd) in Novikoff hepatoma in the rat: effects of dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as determined by 19F-NMR spectroscopy. J Cancer Res Clin Oncol (1991) 0.81
Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol (1993) 0.81
A dose-response study on urethane carcinogenesis in rats and mice. Int J Cancer (1977) 0.81
Influence of nicotine on N-nitrosomethylurea-induced mammary tumors in rats. Klin Wochenschr (1984) 0.81
Local carcinogenicity os some environmentally relevant polycyclic aromatic hydrocarbons after lifelong topical application to mouse skin. Arch Geschwulstforsch (1980) 0.81
Influence of five different postnatal lifelong treatments on the transplacental carcinogenicity of ethylnitrosourea in Sprague-Dawley rats. Cancer Lett (1976) 0.80
Investigations on the carcinogenicity of the artificial sweeteners sodium cyclamate and sodium saccharin in rats in a two-generation experiment. Arzneimittelforschung (1984) 0.80
[Hepatotoxic and cacinogenic effect of diethylnitrosamine in swine]. Naturwissenschaften (1967) 0.80
Influence of reducing luxury calories in the treatment of experimental mammary carcinoma. Br J Cancer (1992) 0.80
Estrogen-linked 2-chloroethylnitrosoureas: anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactions. Eur J Cancer Clin Oncol (1986) 0.80
Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass. Anticancer Res (2001) 0.79
New cytostatics--more activity and less toxicity. Cancer Treat Rev (1990) 0.79
Life-span investigations for carcinogenicity of some immune-stimulating, immunodepressive and neurotropic substances in Sprague-Dawley-rats. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.79
Combination experiments with very low doses of three genotoxic N-nitrosamines with similar organotropic carcinogenicity in rats. Carcinogenesis (1987) 0.79
[Experimental investigations in "syncarcinogenesis". VI. Addition of minimum doses of 4 different liver carcinogens in rats in liver cancer development]. Z Krebsforsch (1970) 0.79
[Carcinogenesis and immunosuppression]. Dtsch Med Wochenschr (1971) 0.79
Anticancer efficacy of 2-chloroethylnitrosocarbamoyl derivatives of L-alanine, glycine, their di- and tripeptide homologues and the respective amides in methylnitrosourea-induced rat mammary carcinoma. Br J Cancer (1989) 0.79
[Effect of immunomodulation following allogeneic blood transfusion on tumor neogenesis and growth--experimental studies in rats]. Arch Geschwulstforsch (1987) 0.79
New cytostatics with experimentally different toxic profiles. Cancer Treat Rev (1987) 0.79
[Activities of the research advisory body on Smoking and Health]. MMW Munch Med Wochenschr (1980) 0.79
[Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer]. Dtsch Med Wochenschr (1987) 0.79
Do primiparas aged 40 years or older carry an increased obstetric risk? Prev Med (1999) 0.79
[Cancerogenic activity of diethylnitrosamine on pigs]. Z Krebsforsch (1969) 0.79
Characterization of in vitro chemosensitivity of perioperative human ovarian malignancies by adenosine triphosphate chemosensitivity assay. Am J Obstet Gynecol (1991) 0.79
Implications of the carcinogenic hazard of low doses of three hepatocarcinogenic N-nitrosamines. Jpn J Cancer Res (1990) 0.78
Leukemias induced by ethylnitrosourea in Wistar rats: incidence and chemotherapy. Leuk Res (1979) 0.78
Alkyl phosphocholines: toxicity and anticancer properties. Lipids (1987) 0.78
Carcinogenicity in rats of high oral doses of N-nitroso-carbaryl, a nitrosated pesticide. Cancer Lett (1976) 0.78
[Side-effects of cytostatic therapy with special reference to potential carcinogenic effects]. Internist (Berl) (1971) 0.78
Chemotherapeutic studies on N-nitrosoacetoxymethyl-methylamine-and 1,2-dimethylhydrazine-induced colonic tumors in rats: monotherapy with 5-fluorouracil, ftorafur, CGP 6809, and CGP 15'720A. J Cancer Res Clin Oncol (1982) 0.78
Development of second malignancies in rats after cure of acute leukemia L 5222 by single doses of 2-chloroethylnitrosoureas. J Cancer Res Clin Oncol (1979) 0.78
[Toxicological problems of iatrogenic carcinogenesis (report) (author's transl)]. Verh Dtsch Ges Pathol (1972) 0.78
Carcinogenic activity in rats of combined treatment with cyclophosphamide, methotrexate and 5-fluorouracil. Int J Cancer (1981) 0.78
New estradiol-linked nitrosoureas: can the pharmacokinetic properties help to explain the pharmacodynamic activities? Eur J Cancer Clin Oncol (1989) 0.78
Experimental investigations on the influence upon the chemical carcinogenesis. IIIrd communication: studies with 1,2-dimethylhydrazine. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.78
Syncarcinogenic action of polycyclic hydrocarbons in automobile exhaust gas condensates. IARC Sci Publ (1977) 0.78
Feasible model for locoregional and systemic longterm administration of drugs and concomitant blood sampling in Sprague-Dawley rats. J Cancer Res Clin Oncol (1987) 0.78
[Influence of immunosuppressive drugs on the canceration of rat liver by diethylnitrosamine and on the induction of fibrosarcoma by 3,4 benzpyrene]. Arzneimittelforschung (1971) 0.78
Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice. J Cancer Res Clin Oncol (1984) 0.78
Experiments on the toxicity of locoregional liver chemotherapy with 5-fluoro-2'-deoxyuridine and 5-fluorouracil in an animal model. Recent Results Cancer Res (1986) 0.77
Pharmacokinetics of the osteotropic diphosphonate 3-amino-1-hydroxypropane-1,1-diphosphonic acid in mammals. Arzneimittelforschung (1987) 0.77
First experiments with locoregional chemotherapy in the treatment of autochthonous rat hepatoma. Arch Geschwulstforsch (1988) 0.77
The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas. J Cancer Res Clin Oncol (1984) 0.77
[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences]. Urologe A (1984) 0.77
Effect of different diets on the ratio of plasma lipids/vitamin A and E in female Sprague-Dawley rats with MNU-induced mammary carcinomas. Arch Geschwulstforsch (1985) 0.77
What's new in mutagenicity and carcinogenicity--status of short-term assay systems as tools in genetic toxicology and carcinogenesis. Pathol Res Pract (1987) 0.77
Synthesis, antitumor activity, distribution and toxicity of 4-[4-[bis(2-chloroethyl)amino]phenyl]-1-hydroxybutane-1 1-bisphosphonic acid (BAD), a new lost derivative with increased accumulation in rat osteosarcoma. J Cancer Res Clin Oncol (1986) 0.77